A recent study identified a microglia–T cell communication axis that retains CD8+ T cells in brains with amyloid pathology. Data from this study indicate that CD8+ T cells restrict Alzheimer’s disease pathogenesis.
References
Reagin, K. L. & Funk, K. E. Curr. Opin. Neurobiol. 76, 102603 (2022).
Gate, D. et al. Nature 577, 399–404 (2020).
Unger, M. S. et al. Brain Behav. Immun. 89, 67–86 (2020).
Su, W. et al. Nat. Immunol. 24, https://doi.org/10.1038/s41590-023-01604-z (2023).
Schenkel, J. M. & Masopust, D. Immunity 41, 886–897 (2014).
Altendorfer, B. et al. J. Immunol. 209, 1272–1285 (2022).
Baruch, K. et al. Nat. Med. 22, 135–137 (2016).
Rosenzweig, N. et al. Nat. Commun. 10, 465 (2019).
Keren-Shaul, H. et al. Cell 169, 1276–1290.e17 (2017).
Deczkowska, A. et al. Cell 173, 1073–1081 (2018).
Chen, X. et al. Nature 615, 668–677 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Reagin, K.L., Funk, K.E. CD8+ T cells pump the brakes on Alzheimer’s disease. Nat Immunol 24, 1597–1598 (2023). https://doi.org/10.1038/s41590-023-01622-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-023-01622-x
- Springer Nature America, Inc.